Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-26 @ 2:33 AM
NCT ID:
NCT01318902
Group ID:
EG002
Title:
Dose Expansion Cohort: Ixazomib 4.0 mg (PI Naive)
Description:
Ixazomib 4.0 mg, capsule, orally, on Days 1, 8 and 15 during a 28-day treatment cycle until progressive disease (PD) or unacceptable toxicity, for participants with relapsed or refractory amyloidosis and who were not treated with any other proteasome inhibitor (PI). Duration of treatment was up to 12 months unless the investigator and sponsor determined the participant would benefit from therapy beyond 12 months.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
5
Other Number Affected:
5
Other Number At Risk:
5
Study:
NCT01318902
Results Section:
NCT01318902
Adverse Events Module:
NCT01318902